Literature DB >> 12124554

Beware Swan-Ganz complications. Perioperative management.

T Asteri1, I Tsagaropoulou, K Vasiliadis, I Fessatidis, E Papavasi-Liou, P Spyrou.   

Abstract

Since the introduction of the pulmonary artery catheter (PAC) in 1970 by Swan et al., various complications are recognized with the insertion and the use of Swan-Ganz catheter. We present two different cases with rare but life threatening complications which had been successfully managed. The first case is a carotid cannulation with an 8.5 Fr introducer sheath, in an attempt to insert a pulmonary catheter via the right internal jugular vein. Two weeks later, the patient was re-admitted to the hospital and when an arteriovenous fistulae (carotid artery-internal jugular vein) was diagnosed, he was treated surgically. The second case presents the rupture of the right atrium in the conjunction with the superior vena cava. This serious cardiac complication was developed during the floatation of the PAC and the lesion was repaired while the mitral valve replacement was in progress.

Entities:  

Mesh:

Year:  2002        PMID: 12124554

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  4 in total

1.  Impact of ultrasonography on central venous catheter insertion in intensive care.

Authors:  Gopal B Palepu; Juneja Deven; M Subrahmanyam; S Mohan
Journal:  Indian J Radiol Imaging       Date:  2009 Jul-Sep

2.  Diagnosis and Rescue of a Kinked Pulmonary Artery Catheter.

Authors:  Nicolas J Mouawad; Erica J Stein; Kenneth R Moran; Michael R Go; Thomas J Papadimos
Journal:  Case Rep Anesthesiol       Date:  2015-05-13

3.  What is the best site for central venous catheter insertion in critically ill patients?

Authors:  Jean-François Timsit
Journal:  Crit Care       Date:  2003-03-28       Impact factor: 9.097

4.  The incidence of complications of central venous catheters at an intensive care unit.

Authors:  A H Akmal; M Hasan; A Mariam
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.